Clincosm LogoSign in Get a demo

Insulin Resistance

Showing 26 - 50 of 881
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aging, Insulin Resistance Trial in Madison (Everolimus 0.5 MG once per day, Everolimus 5 MG once per week, Placebo once per day)

Recruiting
  • Aging
  • Insulin Resistance
  • Everolimus 0.5 MG once per day
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin-Madison
Apr 19, 2023

Long COVID, Insulin Resistance, Insulin Sensitivity Trial in Palo Alto (Adipose Tissue Biopsy, Steady State Plasma Glucose

Not yet recruiting
  • Long COVID
  • +2 more
  • Adipose Tissue Biopsy
  • Steady State Plasma Glucose (SSPG) Test
  • Palo Alto, California
  • +1 more
Apr 27, 2023

Insulin Resistance Trial (radiofrquency device)

Not yet recruiting
  • Insulin Resistance
  • radiofrquency device
  • (no location specified)
Apr 17, 2023

Prevalence of IR in Overweight and Obese Adolescents

Not yet recruiting
  • Insulin Resistance
  • Blood Tests; Serum Fasting Insulin and Glucose
  • (no location specified)
Apr 11, 2023

Obesity, Metabolic Disease, Metabolic Syndrome Trial in Ann Arbor (MICT Exercise, No Exercise (Control))

Recruiting
  • Obesity
  • +5 more
  • MICT Exercise
  • No Exercise (Control)
  • Ann Arbor, Michigan
    University of Michigan School of Kinesiology
Mar 28, 2023

Spinal Cord Injuries, Tetraplegia, Paraplegia Trial in Miami (Ursolic Acid, Strength Training)

Not yet recruiting
  • Spinal Cord Injuries
  • +5 more
  • Ursolic Acid
  • Strength Training
  • Miami, Florida
    University of Miami - Miami Project to Cure Paralysis
Mar 7, 2023

Obesity, Obesity, Abdominal, Insulin Resistance Trial in Kyiv, Lviv (Postbiotic, Placebo)

Recruiting
  • Obesity
  • +5 more
  • Postbiotic
  • Placebo
  • Kyiv, Ukraine
  • +3 more
Mar 14, 2023

Type2 Diabetes, Obesity, Insulin Resistance Trial in Kyiv, Lviv (Probiotic, Placebo)

Completed
  • Type2 Diabetes
  • +3 more
  • Probiotic
  • Placebo
  • Kyiv, Ukraine
  • +3 more
Mar 10, 2023

Perioperative Care, Intermittent Fasting, Carbohydrate Loading Trial in Amsterdam (Time-restricted feeding, Carbohydrate

Not yet recruiting
  • Perioperative Care
  • +5 more
  • Time-restricted feeding
  • Carbohydrate loading
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC location AMC
Feb 27, 2023

Insulin Resistance, Hypertriglyceridemia Trial in Amsterdam (Standardized Dinner, Premeal exercise)

Not yet recruiting
  • Insulin Resistance
  • Hypertriglyceridemia
  • Standardized Dinner
  • Premeal exercise
  • Amsterdam, Netherlands
    AMC Amsterdam
Feb 15, 2023

Insulin Resistance, Hyperinsulinemia, Dyslipidemias Trial in New York (drug, device, diagnostic test, dietary supplement)

Recruiting
  • Insulin Resistance
  • +2 more
  • Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 3, 2023

Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per

Recruiting
  • Hyperinsulinemia
  • +3 more
  • Diazoxide oral suspension, 1 mg per kg per dose
  • +3 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 6, 2023

Insulin Resistance, Obesity Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Placebo,

Not yet recruiting
  • Insulin Resistance
  • Obesity
  • Placebo
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 10, 2023

Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)

Recruiting
  • Insulin Resistance
  • +4 more
  • Insulin human
  • +8 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 2, 2023

Insulin Resistance Trial in Amsterdam (fructose)

Recruiting
  • Insulin Resistance
  • fructose
  • Amsterdam, Netherlands
    Amsterdam UMC location AMC
Jan 29, 2023

Insulin Resistance Trial in Marseille (Propolis, Placebo)

Completed
  • Insulin Resistance
  • Propolis
  • Placebo
  • Marseille, France
    CIC La conception
Feb 6, 2023

Obesity, Prediabetic State, Dyslipidemias Trial (INOSITOLS, CELLULOSE)

Not yet recruiting
  • Obesity
  • +3 more
  • INOSITOLS
  • CELLULOSE
  • (no location specified)
Jan 19, 2023

Identifying Risk for Diabetes and Heart Disease in Women

Completed
  • Obesity
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Insulin Resistance Trial in Mexico City (Vegetal protein, Animal protein)

    Recruiting
    • Insulin Resistance
    • Vegetal protein
    • Animal protein
    • Mexico City, Mexico
    • +1 more
    Jan 22, 2023

    Insulin Resistance, Impaired Glucose Tolerance, PreDiabetes Trial (Fibre supplement (potato-pectin), Placebo, High-protein diet)

    Recruiting
    • Insulin Resistance
    • +3 more
    • Fibre supplement (potato-pectin)
    • +2 more
    • Maastricht, Netherlands
      Maastricht University
    Jan 11, 2023

    Studying Infant Nutrition and Blood Sugar

    Active, not recruiting
    • Insulin Resistance
    • Obesity
      • Rochester, New York
        Clinical Research Center of the University of Rochester Medical
      Jan 11, 2023

      Mild Cognitive Impairment, Insulin Resistance, Diabetes, Type 2 Trial in Singapore (Metformin, Intensive Lifestyle Intervention,

      Terminated
      • Mild Cognitive Impairment
      • +2 more
      • Singapore, Singapore
        SingHealth Polyclinics - Marine Parade Polyclinic
      Jan 9, 2023

      Insulin Resistance, Healthy, Obesity Trial in Nashville (Phentolamine, Saline, Sodium Nitroprusside)

      Recruiting
      • Insulin Resistance
      • +2 more
      • Nashville, Tennessee
        Autonomic Dysfunction Center
      Jan 2, 2023

      Overweight and Obesity, Insulin Resistance, Dysbiosis Trial in Maastricht (Indigestible fiber (classified), Placebo)

      Completed
      • Overweight and Obesity
      • +2 more
      • Indigestible fiber (classified)
      • Placebo
      • Maastricht, Netherlands
        Department of Human Biology, Maastricht University Medical Centr
      Dec 23, 2022

      Insulin Resistance Trial in Christchurch (TLC-3595 Dose 1, TLC-3595 Dose 2, Placebo)

      Not yet recruiting
      • Insulin Resistance
      • TLC-3595 Dose 1
      • +2 more
      • Christchurch, New Zealand
        New Zealand Clinical Research
      Dec 16, 2022